Haleon (HLN) Net Income (2021 - 2025)

Haleon's (HLN) quarterly Net Income came in at $1.1 billion in Q4 2025, down 51.46% on a QoQ basis from $2.2 billion in Q4 2023.

Haleon (HLN) Net Income (2021 - 2025) Analysis & Trends

Haleon (HLN) has 4 years of Net Income data on file, last reported at $1.1 billion in Q4 2025.

Quarterly Net Income changed N/A year-over-year to $1.1 billion in Q4 2025, while the trailing twelve-month figure through Jun 2026 was $1.1 billion (changed N/A YoY) and the FY2025 annual result came in at $2.2 billion, up 18.52% from the prior year.
Net Income slipped to $1.1 billion in Q4 2025, from $2.2 billion in the prior quarter.
In the past five years, Net Income ranged from a high of $2.2 billion in Q4 2023 to a low of $652.0 million in Q2 2023.
A 4-year average of $1.5 billion and a median of $1.5 billion in 2022 frame the typical range for Net Income.
Annual changes were most pronounced in 2022 — Net Income declined 0.63% — and 2023, when it climbed 5.76%.
Tracing HLN's Net Income over 4 years: stood at $2.1 billion in 2021, then dropped by 0.63% to $2.1 billion in 2022, then gained by 5.76% to $2.2 billion in 2023, then plunged by 51.46% to $1.1 billion in 2025.
The last three Net Income figures came in at $1.1 billion (Q4 2025), $2.2 billion (Q4 2023), and $652.0 million (Q2 2023), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Income (Qtr)
1	Haleon	44.07 Bn	43.10 Bn	-	-
2	Teva Pharmaceutical Industries	43.41 Bn	39.75 Bn	2.15 Bn	-576.00 Mn
3	Zoetis	31.83 Bn	30.15 Bn	1.05 Bn	866.00 Mn
4	Takeda Pharmaceutical	28.77 Bn	22.97 Bn	5.10 Bn	-69.36 Mn
5	United Therapeutics	22.27 Bn	19.61 Bn	683.80 Mn	333.00 Mn
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	-118.80 Mn
7	Neurocrine Biosciences	15.65 Bn	15.26 Bn	935.80 Mn	144.40 Mn
8	Elanco Animal Health	11.93 Bn	11.40 Bn	798.00 Mn	54.00 Mn
9	Dr Reddys Laboratories	10.16 Bn	10.00 Bn	-	-
10	Alkermes	8.20 Bn	7.55 Bn	397.90 Mn	524,000.00

Download Data